Kodiak Sciences Inc. 8-K

What Happened

• Kodiak Sciences Inc. announced and filed a Form 8-K on March 31, 2026 to publish its financial results and business highlights for the quarter and year ended December 31, 2025.
• The company attached a press release reporting those results as Exhibit 99.1. The Form 8-K was signed by Victor Perlroth, M.D., Chief Executive Officer.
• The filing states, per Form 8-K instruction, that the furnished press release is not "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings except where expressly stated.

Key Details

• Filing date: March 31, 2026.
• Reporting period: quarter and year ended December 31, 2025.
• Press release attached as Exhibit 99.1 to the Form 8-K.
• Form signed by Victor Perlroth, M.D., Chief Executive Officer.

Why It Matters

• This 8-K indicates Kodiak has released its Q4 and full-year 2025 results; investors should read the attached press release (Exhibit 99.1) for revenue, earnings, cash position, R&D updates, and any guidance or business highlights.
• Because the release is furnished (not "filed"), it is provided for disclosure but carries different legal treatment under the Exchange Act; review the exhibit and any accompanying investor presentation or earnings call for the detailed financials and management commentary.